Statin trials in progress: unanswered questions

Curr Atheroscler Rep. 2001 Jan;3(1):9-13. doi: 10.1007/s11883-001-0004-0.

Abstract

Five years ago, many critics questioned the value of lipid-lowering therapy. Today, the clinical benefits of statins are well documented, but the challenge remains to fully implement these benefits across the wide spectrum of the at-risk population, and continue to advance our understanding regarding the potential for the benefits of statins across an even broader range of select patient populations.

Publication types

  • Review

MeSH terms

  • Atorvastatin
  • Clinical Trials as Topic
  • Coronary Disease / etiology
  • Coronary Disease / prevention & control
  • Drug Therapy, Combination
  • Fatty Acids, Monounsaturated / therapeutic use
  • Fluvastatin
  • Heptanoic Acids / therapeutic use
  • Humans
  • Hypolipidemic Agents / therapeutic use*
  • Indoles / therapeutic use
  • Lovastatin / therapeutic use
  • Pravastatin / therapeutic use
  • Pyridines / therapeutic use
  • Pyrroles / therapeutic use
  • Simvastatin / therapeutic use

Substances

  • Fatty Acids, Monounsaturated
  • Heptanoic Acids
  • Hypolipidemic Agents
  • Indoles
  • Pyridines
  • Pyrroles
  • Fluvastatin
  • Lovastatin
  • Atorvastatin
  • Simvastatin
  • cerivastatin
  • Pravastatin